Benzinga | Oct 6, 2020 08:08AM EDT

BTIG Reiterates Buy on Neuronetics, Raises Price Target to $10

BTIG analyst Marie Thibault reiterates Neuronetics (NASDAQ:STIM) with a Buy and raises the price target from $6 to $10.